Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Granulosa Cell Tumor of the Ovary
Welcome,
Profile
Billing
Logout
1 Company
0 Products
0 Products
0 Mechanisms of Action
0 Trials
4 News
||||||||||
ketoconazole
/
Generic mfg.
Enrollment change, Trial termination, Trial primary completion date, Metastases:
GreKo: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary
(clinicaltrials.gov) - Jan 22, 2015
P2
, N=6, Terminated,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes
N=17 --> 6 | Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Nov 2014; Insufficient recruitment rate
||||||||||
ketoconazole
/
Generic mfg.
Enrollment open, Metastases:
GreKo: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary
(clinicaltrials.gov) - Dec 11, 2012
P2
, N=17, Recruiting,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes
N=17 --> 6 | Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Nov 2014; Insufficient recruitment rate Not yet recruiting --> Recruiting
||||||||||
ketoconazole
/
Generic mfg.
New P2 trial, Metastases:
GreKo: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary
(clinicaltrials.gov) - Apr 22, 2012
P2
, N=17, Recruiting,
Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes